Skip to content

Advancing Telestroke Care: A Prospective Observational Study

Advancing Telestroke Care: A Prospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01226862
Acronym
ATC
Enrollment
508
Registered
2010-10-22
Start date
2010-12-31
Completion date
2013-12-31
Last updated
2013-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Telemedicine, Telestroke

Brief summary

This study will promote the development and economic sustainability of telemedicine for acute stroke treatment.

Detailed description

The goal of this study is to promote the development and economic sustainability of telemedicine for acute stroke treatment. The study's objectives are 1) to determine if the use of telemedicine consultations for stroke patients will improve their care per guidelines compared to stroke patients treated by control hospitals; and 2) to determine if the care per guidelines provided via telemedicine consultations for stroke patients will be similar or equivalent to care per guidelines provided to stroke patients treated at hub hospitals. The Advancing Telestroke Care study will establish treatment and outcomes in three distinct study cohorts: hub telemedicine hospital, spoke telemedicine hospital and non-telemedicine control hospital.

Interventions

None listed

Sponsors

University of Southern California
CollaboratorOTHER
Mayo Clinic
CollaboratorOTHER
Swedish Medical Center
CollaboratorOTHER
University of Utah
CollaboratorOTHER
California Pacific Medical Center
CollaboratorOTHER
National Stroke Association, United States
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age greater than or equal to 18 years old * Acute ischemic stroke within 12 hours of stroke onset

Exclusion criteria

* Life expectancy less than 90 days * Patient unwilling to participate in study

Design outcomes

Primary

MeasureTime frameDescription
IV tPA administrationDay 7/DischargeCorrectness of decisions regarding IV tPA administration in acute stroke

Secondary

MeasureTime frameDescription
Multiple Study AssessmentsDay 7 and/or Day 30 and/or Day 90 and/or at dischargeThere are 23 assessments, after stroke, for outcome measures. They include: hospital transfers, treatment with reperfusions therapies, treatment with antiplatelets, hypertension treatment, hyperglycemia treatment, hyperlipidemia treatment, symptomatic ICH, mortality, imaging/diagnostic data, stroke and rehab scale scores, number of hospitalizations since last assessment, hospital LOS, discharge location, number of physician visits, and work status.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026